These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18415123

  • 1. Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas.
    Briese J, Schulte HM, Sajin M, Bamberger C, Redlin K, Milde-Langosch K, Löning T, Bamberger AM.
    Virchows Arch; 2008 Jul; 453(1):89-96. PubMed ID: 18415123
    [Abstract] [Full Text] [Related]

  • 2. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

  • 3. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
    Heckl M, Schmoeckel E, Hertlein L, Rottmann M, Jeschke U, Mayr D.
    PLoS One; 2018 Jun; 13(2):e0192881. PubMed ID: 29451900
    [Abstract] [Full Text] [Related]

  • 4. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
    Ozkara SK, Corakci A.
    Pathol Oncol Res; 2004 Jun; 10(2):89-97. PubMed ID: 15188025
    [Abstract] [Full Text] [Related]

  • 5. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME, Bur ME, Kurman RJ.
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [Abstract] [Full Text] [Related]

  • 6. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H, Wu RC, Wang Y, Sinno AK, Miyamoto T, Shiozawa T, Wang TL, Fader AN, Shih IeM.
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [Abstract] [Full Text] [Related]

  • 7. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H.
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [Abstract] [Full Text] [Related]

  • 8. MSX1-A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas.
    Eppich S, Kuhn C, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Gallwas J, Heidegger HH.
    Int J Mol Sci; 2020 Jun 25; 21(12):. PubMed ID: 32630554
    [Abstract] [Full Text] [Related]

  • 9. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH.
    Mod Pathol; 2007 Dec 25; 20(12):1263-8. PubMed ID: 17885673
    [Abstract] [Full Text] [Related]

  • 10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH.
    Cancer Res; 2003 Oct 01; 63(19):6195-9. PubMed ID: 14559803
    [Abstract] [Full Text] [Related]

  • 11. Uterine sarcomas: a review.
    D'Angelo E, Prat J.
    Gynecol Oncol; 2010 Jan 01; 116(1):131-9. PubMed ID: 19853898
    [Abstract] [Full Text] [Related]

  • 12. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J.
    Mod Pathol; 1996 Dec 01; 9(12):1165-9. PubMed ID: 8972476
    [Abstract] [Full Text] [Related]

  • 13. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J, Yokoyama Y, Futagami M, Mizunuma H, Yoshioka H, Washiya K, Hana K, Endou H, Okayasu I.
    Int J Gynecol Cancer; 2014 May 01; 24(4):659-63. PubMed ID: 24694899
    [Abstract] [Full Text] [Related]

  • 14. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA.
    Mod Pathol; 2006 Aug 01; 19(8):1091-100. PubMed ID: 16648864
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in uterine sarcoma.
    Gadducci A.
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec 01; 25(6):783-95. PubMed ID: 21764643
    [Abstract] [Full Text] [Related]

  • 16. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
    Ambros RA, Vigna PA, Figge J, Kallakury BV, Mastrangelo A, Eastman AY, Malfetano J, Figge HL, Ross JS.
    Cancer; 1994 Mar 15; 73(6):1686-92. PubMed ID: 8156496
    [Abstract] [Full Text] [Related]

  • 17. Hysteroscopic and immunohistochemical findings in type I and type II endometrial carcinomas.
    Maia H, Maltez A, Fahel P, Coutinho E.
    J Am Assoc Gynecol Laparosc; 2001 May 15; 8(2):222-30. PubMed ID: 11342729
    [Abstract] [Full Text] [Related]

  • 18. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
    Orlandi A, Ferlosio A, Ciucci A, Francesconi A, Lifschitz-Mercer B, Gabbiani G, Spagnoli LG, Czernobilsky B.
    Mod Pathol; 2006 Jun 15; 19(6):797-803. PubMed ID: 16575402
    [Abstract] [Full Text] [Related]

  • 19. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.
    Am J Surg Pathol; 2008 Feb 15; 32(2):304-15. PubMed ID: 18223334
    [Abstract] [Full Text] [Related]

  • 20. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
    Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK.
    Mod Pathol; 2008 Jul 15; 21(7):912-23. PubMed ID: 18487993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.